| Serial in vivo spectroscopic nuclear magnetic resonance imaging of lactate and extracellular pH in rat gliomas shows redistribution of protons away from sites of glycolysis P Provent, M Benito, B Hiba, R Farion, P López-Larrubia, P Ballesteros, ... Cancer research 67 (16), 7638-7645, 2007 | 98 | 2007 |
| Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti‐angiogenic drug effects B Lemasson, T Christen, X Tizon, R Farion, N Fondraz, P Provent, ... NMR in Biomedicine 24 (5), 473-482, 2011 | 42 | 2011 |
| Near‐Infrared‐Emitting BODIPY‐trisDOTA111In as a Monomolecular Multifunctional Imaging Probe: From Synthesis to In Vivo Investigations N Maindron, M Ipuy, C Bernhard, D Lhenry, M Moreau, S Carme, A Oudot, ... Chemistry-A European Journal 22 (36), 12670-12674, 2016 | 31 | 2016 |
| BODIPY: A highly versatile platform for the design of bimodal imaging probes D Lhenry, M Larrouy, C Bernhard, V Goncalves, O Raguin, P Provent, ... Chemistry–A European Journal 21 (37), 13091-13099, 2015 | 29 | 2015 |
| Assessment of metabolic changes in the striatum of a rat model of parkinsonism: an in vivo 1H MRS study N Kickler, E Lacombe, C Chassain, F Durif, A Krainik, R Farion, P Provent, ... NMR in Biomedicine: An International Journal Devoted to the Development and …, 2009 | 25 | 2009 |
| Blood–brain barrier permeability to manganese and to Gd‐DOTA in a rat model of transient cerebral ischaemia E Grillon, P Provent, O Montigon, C Segebarth, C Rémy, EL Barbier NMR in Biomedicine 21 (5), 427-436, 2008 | 21 | 2008 |
| 2D J‐resolved spiral spectroscopic imaging at 7 T: Application to mobile lipid mapping in a rat glioma B Hiba, R Serduc, P Provent, R Farion, C Rémy, A Ziegler Magnetic Resonance in Medicine: An Official Journal of the International …, 2004 | 20 | 2004 |
| The ammonium-induced increase in rat brain lactate concentration is rapid and reversible and is compatible with trafficking and signaling roles for ammonium P Provent, N Kickler, EL Barbier, A Bergerot, R Farion, S Goury, ... Journal of Cerebral Blood Flow & Metabolism 27 (11), 1830-1840, 2007 | 19 | 2007 |
| Abstract 1875A: Preclinical proof of concept for the first Nanocyclix TKI-PET radiotracer targeting activated EGFR positive lung tumors P Genne, C Berthet, O Raguin, S Chalon, X Tizon, S Serriere, P Provent, ... Cancer Research 77 (13 Supplement), 1875A-1875A, 2017 | 7 | 2017 |
| Eribulin alters vascular function in human triple-negative (TN) breast MX-1 and MDA-MB-231 tumor xenograft models as measured by DCE-MRI. PJ McCracken, K Ito, M Yanagimachi, X Tizon, P Provent, S Xu, N Kumar, ... Cancer Research 73 (8 Supplement), 4502, 2013 | 4 | 2013 |
| In-vivo metabolic characterization of healthy prostate and orthotopic prostate cancer in rats using proton magnetic resonance spectroscopy at 4.7 T P Walker, P Provent, X Tizon, G Créhange, O Duchamp, F Brunotte, ... Acta Radiologica 54 (1), 121-126, 2013 | 4 | 2013 |
| Computer-assisted teaching in class situation: a high-school math lab on vectors M Marchal, P Provent, F Ruyer, P Djoharian, F Neyret International Conference on Technologies for E-Learning and Digital …, 2006 | 4 | 2006 |
| The dual selective VEGFR-FGFR kinases inhibitor E-3810 decreases tumor perfusion and inhibits tumor growth: an analysis using dynamic contrast-enhanced magnetic resonance imaging F Bichat, X Tizon, P Provent, V Bari, R Cereda, G Camboni, E Cavalletti Cancer Research 70 (8 Supplement), 1367-1367, 2010 | 3 | 2010 |
| Avastin alone or combined to Campto® reduces local blood oxygen saturation in an orthotopic human glioblastoma model (U87-MG) in nude rats B Lemasson, T Christen, N Pannetier, R Farion, C Segebarth, X Tizon, ... Proc. 17th Annu. Meeting Int. Soc. Mag. Reson. Med, a1013, 2009 | 1 | 2009 |
| Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and antiangiogenic drug effects R FARION, N FONDRAZ, P PROVENT, C SEGEBARTH, E BARBIER, ... | 1* | |
| Development of an orthotopic murine model of a patient-derived pancreatic adenocarcinoma to evaluate the tissue specificity of two novel fluorescent compounds O Duchamp, C Berthet, P Provent, EMD Chatel, J Longin, S Urbain, ... Cancer Research 80 (16 Supplement), 1659-1659, 2020 | | 2020 |
| Liver preclinical models-acute, chronic and cancer models O Duchamp, G Krysa, R Artus, H Quillery, M Ramelet, V Boullay, ... Cancer Research 80 (16 Supplement), 5638-5638, 2020 | | 2020 |
| Preclinical assessment of external or targeted radiotherapy in combination with immunotherapies and co-development of companion imaging diagnostic O Raguin, C Mirjolet, C Bernhard, P Provent, B Collin, F Denat, F Viviani, ... Cancer Research 79 (13 Supplement), 4082-4082, 2019 | | 2019 |
| In-vitro and in-vivo evaluation of 2 enantiomers of Nanocyclix (R) EGFR targeted PET radiotracer C BERTHET, O Raguin, C Mothes, P Provent, G SERIN, X TIZON, A Oudot, ... EANM'17, 2017 | | 2017 |
| Radiosynthesis of the first [F-18]-Nanocyclix (R) TKI-PET radiotracer targeting activated EGFR positive lung tumors C Mothes, G Viot, C Vala, O Raguin, P Provent, B Collin, A Oudot, ... JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 60, S350-S350, 2017 | | 2017 |
benjamin lemassonResearcher at INSERM - University of Grenoble Alpes -Geverifieerd e-mailadres voor univ-grenoble-alpes.fr
